Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
1,062.401,064.141,071.991,061.02
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
606.74606.74609.84602.33
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
1,238.211,236.601,247.741,232.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
1,718.611,723.231,741.481,717.47
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
637.37638.27642.30638.27
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
853.59854.05858.19851.34
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
218.33218.33219.73217.15
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
3,594.813,620.103,657.473,615.34
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
908.54909.50917.35907.07
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
1,495.001,499.611,517.101,499.61
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
2,398.312,406.822,421.802,404.22
4888:TYO
Stella Pharma Corp
¥445.00
+0.91%
(+4.00) 1D
May 22, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4888...
Open
¥444
High
¥462
Low
¥438
Mkt. cap
15.59B
Avg. vol.
1.46M
Volume
673.20K
52-wk high
¥995
52-wk low
¥200
EPS
-¥23
No. of employees
43
News stories
From sources across the web
About Stella Pharma Corp
CEOTomoyuki Asano
Employees43
FoundedJun 1, 2007
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
92.00M
108.00M
61.00M
62.00M
Cost of goods sold
13.00M
22.00M
1.00M
8.00M
Cost of revenue
13.00M
22.00M
1.00M
8.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
231.00M
233.00M
274.00M
290.00M
Operating expense
231.00M
233.00M
274.00M
290.00M
Total operating expenses
244.00M
255.00M
275.00M
298.00M
Operating income
-152.00M
-147.00M
-214.00M
-236.00M
Other non operating income
-3.00M
-2.00M
12.00M
-29.00M
EBT including unusual items
-156.00M
-150.00M
-204.00M
-268.00M
EBT excluding unusual items
-156.00M
-150.00M
-204.00M
-268.00M
Income tax expense
-
1.00M
1.00M
-
Effective tax rate
-
-0.67%
-0.49%
-
Other operating expenses
-
-
-
-
Net income
-156.00M
-151.00M
-205.00M
-268.00M
Net profit margin
-169.57%
-139.81%
-336.07%
-432.26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.00M
-1.00M
-2.00M
-3.00M
Net interest expenses
-1.00M
-1.00M
-2.00M
-3.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-143.50M
-140.00M
-205.50M
-229.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more